“…OS is the most common primary malignant tumor in children and adolescents, two new cases per million being diagnosed annually. MFOS only comprises 1.0%-3.6% of all OS [6][7][8] ; thus far, only about 350 cases of MFOS have been reported 3,[6][7][8][9][10][11][12][13][14][15][16] . MFOS is characteristically rapidly progressive, poorly response to chemotherapy drugs and has a miserable prognosis in almost every patient.…”